Reported Q: Q1 2025 Rev YoY: -1.3% EPS YoY: +116.0% Move: 0.00%
Encision Inc
ECIA
$0.130 0.00%
Exchange OTC Sector Healthcare Industry Medical Instruments Supplies
Q1 2025
Published: Aug 14, 2024

Company Status Snapshot

Fast view of the latest quarter outcome for ECIA

Reported

Report Date

Aug 14, 2024

Quarter Q1 2025

Revenue

1.63M

YoY: -1.3%

EPS

0.00

YoY: +116.0%

Market Move

0.00%

Previous quarter: Q4 2024

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $1.63M down 1.3% year-over-year
  • EPS of $0.00 increased by 116% from previous year
  • Gross margin of 57.8%
  • Net income of 22.04K
  • "Not available" -
ECIA
Company ECIA

Swipe to view all report sections

Executive Summary

Encision Inc delivered QQ1 2025 results reflecting a modest YoY revenue decline but meaningful sequential improvement and a favorable margin trajectory driven by a lean operating structure and ongoing contribution from the active electrode monitoring (AEM) product suite. Revenue for the quarter was $1.631 million, down 1.34% from the prior-year period, yet up 6.95% QoQ. Gross profit reached $0.943 million with a gross margin of 57.8%, and operating income was $0.028 million, yielding an EBITDA of $0.048 million (margin ~2.93% of revenue). Net income stood at $0.022 million, translating to an EPS of $0.0019. The company generated $0.1175 million in cash from operations and $0.0982 million in free cash flow, supporting a cash balance of $0.270 million at period end and a net debt position of approximately $1.109 million.

Key Performance Indicators

Revenue
Decreasing
1.63M
QoQ: 6.95% | YoY: -1.34%
Gross Profit
Increasing
942.66K
57.80% margin
QoQ: 45.92% | YoY: 9.23%
Operating Income
Increasing
28.34K
QoQ: 107.05% | YoY: 122.14%
Net Income
Increasing
22.04K
QoQ: 105.39% | YoY: 115.74%
EPS
Increasing
0.00
QoQ: 105.48% | YoY: 115.97%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q1 2026 1.60 0.00 +5.1% View
Q3 2025 1.59 0.00 +0.3% View
Q2 2025 1.76 -0.01 -3.9% View
Q1 2025 1.63 0.00 -1.3% View
Q4 2024 1.53 -0.03 -15.6% View